While this review focused on insulin, the findings apply to GLP-1 medications since both are temperature-sensitive peptide hormones requiring similar storage conditions
No default doses
Liang R, Duan SN , Fu M, et al
Last reviewed: May 23, 2026 Last updated: May 23, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
The failure to intensify therapy when treatment targets are not met is termed therapeutic inertia, which is a widely reported phenomenon that is known to negatively affect clinical outcomes, often through contributing to complications emanating from lack of glycemic control [15,16,17,18]
Was that the root cause driving the diabetes